Lithium Street, page-76

Whilst no one wants to get too far ahead wrt how high GRE can go, it's still an interesting exercise, particularly knowing AZS is already trading at around a market cap pf $1.7 billion.

The advantage of GRE is its relatively low shares on issue, thus to get anywhere near AZS market cap the multiples from a current share price is huge.

If we consider the current shares on issue (including 13.21 million in escrow) ie
70,038,888 shares. Current share price $0.545, mkt cap $35 million. At a share price of $1.00 mkt cap only $70 million. At a share price of $5 = mkt cap $350 million. At $20 mkt cap $1.4 billion.

If we fully dilute shares for all unlisted options (they are now "all in the money"), ie
87,288,888 shares, plus $4 million cash received for their conversion:
At current share price of $0.545, a mkt cap of $43.6 million.
At a share price of $1.00 mkt cap = $87.3 million
At a share price of $5.00 mkt cap = $436.4 million.

Any indication that the surface spodumene extends at depth could easily push the share price to around $4 -$5 without an excessive impact on mkt cap.